South Shore Surgical Specialists
786 Montauk Highway
West Islip, NY 11795
​
About Dr. Toset
Born and raised in Norway, Dr. Toset is fluent in Norwegian, English, Polish and German. In his youth he had a passion for helping others, which led to his decision to study medicine. With family heritage stemming from Poland, he decided to attend the prestigious Medical University of Warsaw Poland, where he learned the language, culture and became a medical doctor.
In addition to his medical training in Europe, Dr. Toset has been formally trained and gained his surgical education from world renowned American Institutions. He spent his early career as a medical research assistant at Karmanos Cancer Institute at Wayne State University in Michigan and a research fellow at Columbia University in New York City. His general surgical residency commenced at Yale University and he concluded his 9 years of surgical training with a highly competitive fellowship at Memorial Sloan Kettering Cancer Institute in New York City.
During his general surgical training, Dr. Toset trained with some of the foremost head and neck surgeons in the country. Training with these surgeons helped him discover his passion for the specialty and led him to pursue further specialized training in the field at one of the leading cancer centers in the United States and the world.
Dr Toset is actively involved with The Cancer Institute at Good Samaritan University Hospital. Holding the title as the Cancer Liaison Physician, Dr. Toset serves as the link between the Hospital and the community, between the national standards organizations and the Cancer Institute, and between the Cancer Committee and the various departments at Good Samaritan University Hospital. He participates in peer group meetings to provide direction according to criteria established by the American College of Surgeons Commission on Cancer to meet and exceed cancer program standards and improve clinical practice.
In addition to his busy surgical practice, Dr. Toset finds great pleasure in giving back in the form of teaching medical students and surgical residents. He is a professor of head and neck surgery at New York Institute of Technology and teaches our next generation of doctors on a daily basis.
Education & Fellowships
20o3-2004
Fellowship, Columbia College of Physicians and Surgeons, St. Luke’s/ Roosevelt Hospital, New York, NY, Postdoctoral Vascular Research Fellow under M. David Tilson, M.D.
1998-1999
Fellowship, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, Research Assistant to Richard B. Everson, M.D., M.P.H.
1995-1998
Medical Degree, Medical University of Warsaw, Warsaw, Poland
1993-1995
Bi-Lingual Diploma, International Baccalaureate, Trondheim, Norway
Post Graduate Training
2009-2010
Fellow, Head and Neck Surgical Oncology,
Memorial Sloan-Kettering Cancer Center,
New York, NY
2008-2009
Chief Resident, General Surgery,
North Shore – Long Island Jewish Health System, Manhasset, NY
2006-2008
Resident, General Surgery,
North Shore – Long Island Jewish Health System,
Manhasset, NY
2005-2006
Resident, General Surgery,
Yale-New Haven Hospital,
Yale University School of Medicine, New Haven, CT
2004-2005
Internship, General Surgery,
Yale-New Haven Hospital,
Yale University School of Medicine, New Haven, CT
Research Publications
- 2006, Gastrointestinal manifestations of endocrine disease -
The hormonal interactions among the systems throughout the body are not fully understood; many vague clinical symptoms may in fact be manifestations of underlying endocrine diseases. The aim of the following review is to discuss gastrointestinal manifestations of surgically correctable endocrine diseases, focusing on abnormalities of thyroid function, cancer and finally autoimmune diseases. We also review manifestations of pancreatic endocrine tumors, and multiple endocrine neoplasia.
- 20215, Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer -
Medullary thyroid cancer (MTC) is a rare thyroid cancer accounting for 5 % of all thyroid malignancies. The purpose of our study was to design a predictive nomogram for cancer-specific mortality (CSM) utilizing clinical, pathological, and biochemical variables in patients with MTC.